Amalgamated Bank’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $20.8M | Sell |
360,738
-18,406
| -5% | -$1.06M | 0.14% | 105 |
|
|
2026
Q1 | $23M | Sell |
379,144
-8,892
| -2% | -$518K | 0.18% | 87 |
|
|
2025
Q4 | $20.9M | Sell |
388,036
-20,848
| -5% | -$1M | 0.15% | 102 |
|
|
2025
Q3 | $18.4M | Sell |
408,884
-4,564
| -1% | -$213K | 0.13% | 119 |
|
|
2025
Q2 | $19.1M | Buy |
413,448
+12,577
| +3% | +$617K | 0.15% | 109 |
|
|
2025
Q1 | $24.4M | Buy |
400,871
+3,651
| +0.9% | +$213K | 0.21% | 84 |
|
|
2024
Q4 | $22.5M | Sell |
397,220
-1,202
| -0.3% | -$67.2K | 0.18% | 84 |
|
|
2024
Q3 | $20.6M | Sell |
398,422
-11,479
| -3% | -$538K | 0.17% | 98 |
|
|
2024
Q2 | $17M | Sell |
409,901
-12,282
| -3% | -$550K | 0.15% | 111 |
|
|
2024
Q1 | $22.9M | Sell |
422,183
-72,138
| -15% | -$3.67M | 0.2% | 84 |
|
|
2023
Q4 | $25.4M | Sell |
494,321
-36,084
| -7% | -$1.89M | 0.2% | 82 |
|
|
2023
Q3 | $30.8M | Sell |
530,405
-11,430
| -2% | -$700K | 0.26% | 58 |
|
|
2023
Q2 | $34.6M | Sell |
541,835
-53,678
| -9% | -$3.6M | 0.28% | 57 |
|
|
2023
Q1 | $41.3M | Buy |
595,513
+37,264
| +7% | +$2.63M | 0.35% | 45 |
|
|
2022
Q4 | $40.2M | Sell |
558,249
-18,861
| -3% | -$1.42M | 0.36% | 43 |
|
|
2022
Q3 | $41M | Buy |
577,110
+33,400
| +6% | +$2.42M | 0.4% | 37 |
|
|
2022
Q2 | $41.9M | Sell |
543,710
-34,359
| -6% | -$2.62M | 0.39% | 38 |
|
|
2022
Q1 | $42.2M | Sell |
578,069
-47,972
| -8% | -$3.22M | 0.33% | 50 |
|
|
2021
Q4 | $39M | Buy |
626,041
+22,744
| +4% | +$1.33M | 0.29% | 55 |
|
|
2021
Q3 | $35.7M | Sell |
603,297
-25,101
| -4% | -$1.65M | 0.3% | 52 |
|
|
2021
Q2 | $42M | Buy |
628,398
+499,210
| +386% | +$32.6M | 0.34% | 47 |
|
|
2021
Q1 | $8.16M | Sell |
129,188
-5,487
| -4% | -$341K | 0.31% | 53 |
|
|
2020
Q4 | $8.35M | Sell |
134,675
-411
| -0.3% | -$25.3K | 0.32% | 50 |
|
|
2020
Q3 | $8.14M | Sell |
135,086
-3,416
| -2% | -$206K | 0.35% | 44 |
|
|
2020
Q2 | $8.14M | Sell |
138,502
-233,726
| -63% | -$14M | 0.38% | 45 |
|
|
2020
Q1 | $20.7M | Sell |
372,228
-12,654
| -3% | -$773K | 0.51% | 34 |
|
|
2019
Q4 | $24.7M | Buy |
384,882
+136,917
| +55% | +$7.84M | 0.45% | 35 |
|
|
2019
Q3 | $12.6M | Buy |
247,965
+20,264
| +9% | +$952K | 0.26% | 69 |
|
|
2019
Q2 | $10.3M | Sell |
227,701
-510
| -0.2% | -$23.8K | 0.24% | 75 |
|
|
2019
Q1 | $10.9M | Buy |
228,211
+5,514
| +2% | +$275K | 0.26% | 72 |
|
|
2018
Q4 | $11.6M | Sell |
222,697
-5,197
| -2% | -$279K | 0.33% | 58 |
|
|
2018
Q3 | $14.1M | Sell |
227,894
-6,531
| -3% | -$388K | 0.35% | 60 |
|
|
2018
Q2 | $13M | Buy |
234,425
+11,602
| +5% | +$627K | 0.32% | 59 |
|
|
2018
Q1 | $14.1M | Buy |
222,823
+10,319
| +5% | +$664K | 0.37% | 49 |
|
|
2017
Q4 | $13M | Buy |
212,504
+18,698
| +10% | +$1.17M | 0.35% | 49 |
|
|
2017
Q3 | $12.4M | Buy |
193,806
+3,719
| +2% | +$217K | 0.38% | 46 |
|
|
2017
Q2 | $10.6M | Buy |
190,087
+63,441
| +50% | +$3.45M | 0.35% | 48 |
|
|
2017
Q1 | $6.89M | Sell |
126,646
-54,463
| -30% | -$2.99M | 0.34% | 47 |
|
|
2016
Q4 | $10.6M | Buy |
181,109
+31,637
| +21% | +$1.73M | 0.48% | 37 |
|
|
2016
Q3 | $8.06M | Buy |
149,472
+19
| +0% | +$1.22K | 0.47% | 36 |
|
|
2016
Q2 | $9.11M | Buy |
149,453
+83,188
| +126% | +$5.88M | 0.53% | 32 |
|
|
2016
Q1 | $4.23M | Buy |
66,265
+15,779
| +31% | +$995K | 0.41% | 39 |
|
|
2015
Q4 | $3.47M | Sell |
50,486
-12,819
| -20% | -$847K | 0.43% | 34 |
|
|
2015
Q3 | $3.75M | Buy |
63,305
+2,342
| +4% | +$149K | 0.39% | 38 |
|
|
2015
Q2 | $4.06M | Buy |
60,963
+6,342
| +12% | +$418K | 0.4% | 37 |
|
|
2015
Q1 | $3.52M | Buy |
54,621
+13,434
| +33% | +$841K | 0.43% | 44 |
|
|
2014
Q4 | $2.43M | Sell |
41,187
-6,479
| -14% | -$365K | 0.38% | 46 |
|
|
2014
Q3 | $2.44M | Buy |
47,666
+1,314
| +3% | +$65.6K | 0.36% | 47 |
|
|
2014
Q2 | $2.25M | Buy |
46,352
+4,682
| +11% | +$231K | 0.34% | 48 |
|
|
2014
Q1 | $2.17M | Sell |
41,670
-823
| -2% | -$43.8K | 0.37% | 47 |
|
|
2013
Q4 | $2.26M | Sell |
42,493
-377
| -0.9% | -$19.2K | 0.38% | 43 |
|
|
2013
Q3 | $1.98M | Sell |
42,870
-1,021
| -2% | -$44.8K | 0.64% | 42 |
|
|
2013
Q2 | $1.96M | Buy |
+43,891
| New | +$1.91M | 0.72% | 37 |
|
Other funds holding BMY
Amalgamated Bank's BMY Position: Q2 2026 in Review
Amalgamated Bank reduced its Bristol-Myers Squibb (BMY) stake by 4.9% in Q2 2026, selling an estimated $1.06M and leaving 360,738 shares worth $20.8M. The position accounts for 0.14% of the portfolio, ranked #105.
Amalgamated Bank first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $42.2M in Q1 2022. 1,603 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Amalgamated Bank held 360,738 shares of Bristol-Myers Squibb worth $20.8M as of Q2 2026.
- Amalgamated Bank sold 18,406 Bristol-Myers Squibb shares in Q2 2026, an estimated $1.06M.
- Bristol-Myers Squibb made up 0.14% of Amalgamated Bank's portfolio in Q2 2026, its #105 holding.
- Amalgamated Bank first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
- Amalgamated Bank's Bristol-Myers Squibb position peaked at $42.2M in Q1 2022.
- 1,603 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Amalgamated Bank's 13F filing for Q2 2026, filed 23 Jul 2026.